Biocon [1]Â caused a stir this morning after an Indian financial newspaper claimed the country's biggest biotech was nearing a $400 million buyout deal with a U.S. company. But Biocon executives moved quickly to squelch the story, saying the report was "speculative" and inaccurate. Report [2]
Links:
[1] http://www.fiercebiotech.com/story/biocon-buys-stake-in-german-pharma-company/2008-02-15
[2] http://www.forbes.com/markets/feeds/afx/2008/04/14/afx4885751.html